Primary Record
naratriptan
- In stock
- 9,018 g
- Purity
- 99.8 %
- CAS
- 121679-13-8
Compound Identifiers & Properties
- CAS
- 121679-13-8
- PubChem CID
- 4440
- SMILES
- CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
- Canonical SMILES
- CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1
Names & Synonyms
- naratriptan
- Naramig
- Amerge
- naratriptanum
- Colatan
- 121679-13-8
- naratriptan;
- Amerge;Naramig
- Naratriptan HCl
- Naramig (TN)
- Naratriptan (INN)
- Amerge (TN)
- QX3KXL1ZA2
- Naratriptan [INN:BAN]
- UNII-QX3KXL1ZA2
- RefChem:57988
- NARATRIPTAN [MI]
- CHEMBL1278
- NARATRIPTAN [INN]
- C17H25N3O2S
- D0T3KI
- GTPL45
- NARATRIPTAN [VANDF]
- AC1L1I6A
- Amerge, Naramig,Naratriptan
- CHEBI:7478
- NARATRIPTAN HYDROCHLORIDE
- Naratriptan-d3 Hydrochloride
- SCHEMBL68753
- DTXSID7023354
- NARATRIPTAN [WHO-DD]
- BIDD:GT0312
- N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
- 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-
- AMKVXSZCKVJAGH-UHFFFAOYSA-N
- DTXCID003354
- orb1298731
- ZINC4076
- SCHEMBL29403931
- CID4440
- N02CC02
- NARATRIPTAN [ORANGE BOOK]
- GR-85548A
- HY-B0197
- 2578AH
- ABP000374
- BDBM50073682
- C17-H25-N3-O2-S
- EBC-26632
- FC0032
- MFCD00866221
- AKOS015895854
- AC-5013
- BCP9000978
- CS-2131
- DB00952
- N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
- NCGC00181786-01
- NCGC00181786-03
- NCGC00181786-04
- NCGC00181786-08
- AJ-08192
- AN-11431
- BC201774
- FN170148
- LS-83062
- SC-00604
- TS-09866
- 2-[(R)-(Diphenylmethyl)sulfinyl]acetamide
- AB2000122
- J550.688C
- 5376B
- FT-0656760
- NS00006374
- A10624
- A25336
- C07792
- D08255
- G78311
- N-Methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethanesulfonamide
- N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
- AB01565792_02
- EN300-18567334
- L000432
- Q421315
- N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethane-1-sulfonamide
- BRD-K61337602-003-02-1
- BRD-K61337602-003-03-9
- N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide
- N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide
- N-methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethane-1-sulfonamide
- N-Methyl-3-(1-methyl-4 -piperidinyl)-1H-indole-5-ethansulphonamide
- N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulphonamide
- N-Methyl-3-(1-methyl-4-piperidyl)-1H-indole-5-(ethanesulfonamide)
- N-Methyl-2-(3-(1-methyl-4-piperidinyl)-1H-indole-5-yl)ethanesulfonamide
- N-methyl-2-(3-(1-methyl-4-piperidyl)-1H-indol-5-yl)-ethanesulfonamide
- N-Methyl-2-[3-(1-methylpiperidine-4-yl)-1H-indole-5-yl]ethanesulfonamide
- N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-(ethanesulfonamide)
- 2-[3-(1-Methyl-piperidin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide
- 112111-49-6
- 601-800-8
- InChI=1/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H
- Naratriptan; 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-; N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide; N-Methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide; Naratriptan